Abstract
New guidelines for the management of ankylosis spondylitis provide evidence-based disease management recommendations, which aim to be the ideal standard practice. How robust are these suggestions and are they applicable to the worldwide community of rheumatologists practicing in very different clinics around the globe?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have